logo
Select company
Select metric
$ 75.62KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
41
Sector
72
Industry
84
History
93
$ 3.21Close
$ 2.68 - $ 6.09 52-Week Range
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 75.62K
3/31/2025$ 209.34K
12/31/2024$ 209.34K
9/30/2024$ 204.04K
6/30/2024$ 613.91K
3/31/2024$ 404.57K
12/31/2023$ 404.57K
9/30/2023$ 403.97K
6/30/2023$ -5.86K
3/31/2023$ -16.27K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) CF - Equity stands at $ 23.87M.
  • Over the past 5 years, LIPOCINE INC's average CF - Equity has been $ 10.1M.
  • The median CF - Equity for LIPOCINE INC during this period was $ 306.65K
  • LIPOCINE INC reached its highest CF - Equity over the past 5 years at $ 46.89M.
  • The lowest CF - Equity recorded by LIPOCINE INC in the same timeframe $ -16.27K

LIPOCINE INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
MRKR : MARKER THERAPEUTICS INC $ 14.9MBOLT : BOLT BIOTHERAPEUTICS INC $ 43KTRAW : TRAWS PHARMA INC $ 23.37MNRXS : NEURAXIS INC $ 5MLGVN : LONGEVERON INC $ 14MXAIR : BEYOND AIR INC $ 23.82MDYAI : DYADIC INTERNATIONAL INC $ 48.5KINM : INMED PHARMACEUTICALS INC $ 13.16MLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MINBS : INTELLIGENT BIO SOLUTIONS INC $ 4.6M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

LPCN - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -16.27K

Minimum

Mar 31, 2023

$ 46.89M

Maximum

Mar 31, 2021

$ 10.1M

Average

$ 306.65K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 98.02K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 98.02K
median$ 0
std$ 17.64M